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Abstract
Introduction: Many potential lung transplants are lost because of hypoxemia during donor management. We
hypothesized that the apnea test, necessary to confirm the diagnosis of brain death in potential lung donors, was
involved in the decrease in the ratio of partial pressure of arterial O2 to fraction of inspired O2 (PaO2/FiO2) and that
a single recruitment maneuver performed just after the apnea test can reverse this alteration.
Methods: In this case-control study, we examined the effectiveness of the recruitment maneuver with a
comparison cohort of brain dead patients who did not receive the maneuver. Patients were matched one-to-one
on the basis of initial PaO2/FiO2 and on the duration of mechanical ventilation before the apnea test. PaO2/FiO2
was measured before (T1), at the end (T2) and two hours after apnea test (T3).
Results: Twenty-seven patients were included in each group. The apnea test was associated with a significant decrease
in PaO2/FiO2 from 284 ± 98 to 224 ± 104 mmHg (P < 0.001). The decrease in PaO2/FiO2 between T1 and T3 was
significantly lower in the recruitment maneuver group than in the control group (-4 (-68-57) vs -61 (-110–18) mmHg,
P = 0.02). The number of potential donors with PaO2/FiO2 > 300 mmHg decreased by 58% (95% CI: 28-85%) in the
control group vs 0% (95% CI: 0-34%) in the recruitment maneuver group (P < 0.001).
Conclusions: The apnea test induced a decrease in PaO2/FiO2 in potential lung donors. A single recruitment
maneuver performed immediately after the apnea test can reverse this alteration and may prevent the loss of
potential lung donors.
Introduction
Lung transplantation has become a procedure of choice
for patients with irreversible, progressively disabling,
end-stage pulmonary disease [1]. Among criteria for lung
donors, one of the most significant appears to be arterial
blood gas analysis before harvest since this parameter has
been found to be significantly associated with recipient
prognosis [2]. Arterial blood gas standard criteria for
lung donors are a ratio of arterial oxygen tension (PaO2)
to fractional inspired oxygen (FiO2) of greater than 300
mm Hg and a positive end-expiratory pressure (PEEP) of
5 cm H2O [3]. During the donor management and before
organ procurement, many factors may damage the
respiratory function of the donor. One of these factors is
the apnea test, used to assess the clinical diagnosis of
brain death, as a supplement to the absence of motor
response to a painful stimulus and to the absence of
brainstem reflexes. Usually, the patient has to be discon-
nected from the mechanical ventilator for 8 to 10 min-
utes. If there is a partial pressure of arterial carbon
dioxide of 60 mm Hg or higher or an increase of more
than 20 mm Hg from the baseline value, apnea is con-
firmed [4]. But apnea is known to be responsible for
atelectasis and to decrease PaO2/FiO2 ratio in critically ill
ventilated patients [5,6]. Therefore, the apnea test may
possibly contribute to worsening of the respiratory func-
tion in potential lung donors.
In normal or morbidly obese patients, recruitment
maneuvers (RMs) allow re-opening of atelectasis induced
by apnea and paralysis during general anesthesia, through
an intentional transient increase in transpulmonary pres-
sure. RMs are associated with a significant increase in
oxygenation [7,8]. Moreover, in potential lung donors, a
global protective ventilator strategy that includes small
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tidal volumes, high PEEP, apnea tests performed without
disconnection from the ventilator, and closed circuit for
airway suction was recently shown to significantly
increase the number of eligible and harvested lungs,
although the precise role of each item has not been
determined [9]. Thus, we hypothesized that the apnea
test used to diagnose brain death could impair gas
exchange in potential lung donors and that a single RM
performed immediately after could restore it.
Materials and methods
The study was approved by our ethics committee
(Comité de Protection des Personnes se prêtant à la
RechercheBiomédicale de l’HôpitalPitié-Salpetrière, Paris,
France) and was performed in accordance with the
Declaration of Helsinki. This study was also conducted in
accordance with French law concerning multiple organ
procurement. Medical management of patients and diag-
nosis of brain death were performed as recommended by
the French conference of experts in 2005 [10] and by the
American Academy of Neurology [11]. Brain death was
clinically suspected with usual criteria and had to be con-
firmed with an apnea test, required for the diagnosis of
brain death in France.
The study design was an observational, case controlled
study comparing a recent historic cohort of matched
control patients with prospectively included treated
patients. Before June 2008, the apnea test was performed
without any RM. From June 2008, a new protocol was
established in our unit, providing a single RM performed
immediately after the apnea test administered after the
reconnection to the ventilator in potential donors. The
RM was the only modification made to our lung manage-
ment in brain-dead patients between the historical con-
trol period and the intervention period.
All patients who required an apnea test to confirm
brain death between January 2005 and June 2008 were
included in the historic cohort, independently of the cri-
teria for lung donors. Patients were retained if arterial
blood gas samples taken 2 hours after the apnea test
were available. Blood gas samples were taken at the
request of the organ procurement team and not to guide
lung management of potential donors. We selected, from
among these patients, a matched control group (n = 27,
control group). After June 2008 to December 2009, all
patients (n = 27, RM group) who required an apnea test
to confirm brain death were prospectively included.
Patients were excluded only if an apnea test had not been
performed or achieved. In this nested case cohort study,
patients in the RM group were matched one-to-one on
the basis of initial PaO2/FiO2 ratio and mechanical venti-
lation duration (both identified as putative confounding
factors) with patients who were not recruited among the
cohort. Matching was performed as follows: For each
case, a subset of patients was selected among a historical
cohort on the basis of PaO2/FiO2 ratio and mechanical
ventilation duration (± 10%). A single patient was subse-
quently randomly extracted from this subset of matched
patients by using a random number table. A flowchart of
the study is shown in Figure 1.
Study protocol
All patients received ventilation with tidal volumes of 6
to 10 mL/kg of predicted body weight, PEEP of 5 cm
H2O, respiratory rate adjusted to obtain normocapnia,
and FiO2 adjusted to obtain a pulse oximetry saturation
of greater than 90% (Evita XL; Dräger Medical AG and
Co. KGaA, Lübeck, Germany). When required, airway
suction was performed with an open circuit. Before the
apnea test, the physician checked the absence of con-
founding variables known to interfere with brain-death
diagnosis (low arterial blood pressure, hypothermia, neu-
romuscular relaxation, and circulating psychoactive
drugs). After clinical assessment of unresponsiveness to
noxious pain stimuli and abolition of brainstem reflexes,
the apnea test was performed as follows: First, FiO2 was
increased to 1 for 15 minutes for preoxygenation. At the
end of the preoxygenation period, an initial arterial blood
sample (T1) was taken. Then, the ventilator was discon-
nected for 10 minutes and a continuous flow of oxygen
at a rate of 6 L/minute was administered to maintain
oxygenation. The absence of chest movement indicated a
diagnosis of neuronal death in the medulla oblongata. At
the end of the test and just before the ventilator was
reconnected with the same settings as before the test, a
second arterial blood sample (T2) was taken to demon-
strate a partial pressure of arterial carbon dioxide of 60
mm Hg or higher or an increase of more than 20 mm Hg
from the baseline value.
In the RM group, immediately after reconnection to
the ventilator, an RM was performed as follows: First,
PEEP was increased from 5 to 35 cm H2O and the
respiratory rate was decreased to 0.5 beats per minute for
40 seconds. Next, the initial ventilatory settings were re-
applied. Two hours after the reconnection to the ventila-
tor, a third arterial blood sample (T3) was taken. During
the RM, we observed hemodynamic effects and oxygen
saturation. Hypotension was defined by a diminution of
at least 20% of the initial systolic arterial blood pressure,
and desaturation was defined by a diminution of oxygen
saturation of less than 90%.
Endpoints
The main endpoint was PaO2/FiO2 ratio 2 hours after the
apnea test. The secondary endpoints were PaO2/FiO2
ratio evolution during the apnea test, the proportion of
potential lung donors in relation to arterial blood gas cri-
teria, and complications of the RM in patients.
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Assumptions for the sample size calculation were based
on a preliminary study in 36 brain-injured patients. In
these patients, we observed that PaO2/FiO2 ratio decreased
from 344 ± 116 mm Hg at T1 to 276 ± 124 mm Hg at T2.
To test the hypothesis that RMs prevent 80% of the
decrease of PaO2/FiO2 ratio measured 2 hours after the
apnea test, we calculated that 24 patients per control
group or RM group would need to be studied to achieve a
statistical power of 80% and an alpha risk of 5%.
Statistical analysis
Data are expressed as mean ± standard deviation or
median (25th to 75th interquartiles) for non-normally
distributed variables or as number and percentage and
its 95% confidence interval (CI). The normality of the
distribution of the measured variables was examined
with the Shapiro-Wilk test. Comparison between the
two groups was performed by using the Student t test,
the Mann-Whitney U test, and the Fisher exact method,
as appropriate. All P values were two-tailed, and a P
value of less than 0.05 was considered significant. Statis-
tical analysis was performed by using Prism 5 software
(Software MacKiev Company, Boston, MA, USA).
Results
We prospectively included 27 patients between June
2008 and December 2009, for whom an RM was per-
formed immediately after the apnea test (RM group).
From 2005 to June 2008, we retrospectively screened
197 brain-dead patients. Among them, 63 had complete
data (that is, a well-conducted apnea test and arterial
blood gas taken 2 hours after the apnea test). Among
these 63 control patients, 27 were definitively included
by matching to the 27 RM patients (Figure 1). Baseline
characteristics of the included patients in the control
and RM groups are presented in Table 1.
During the apnea test, PaO2/FiO2 ratio decreased sig-
nificantly from 291 ± 95 mm Hg at T1 to 248 ± 102
Figure 1 Patient flowchart and study design. RM, recruitment maneuver.
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mm Hg at T2 in the control group (P < 0.0001) and
from 277 ± 101 mm Hg at T1 to 201 ± 103 mm Hg at
T2 in the RM group (P < 0.0001). The decrease in
PaO2/FiO2 ratio between T1 and T2 was not signifi-
cantly different between the two groups. After the apnea
test, between T2 and T3, PaO2/FiO2 ratio did not signif-
icantly change in the control group (from 248 ± 102 to
236 ± 103 mm Hg, P = 0.48). In contrast, in the RM
group, PaO2/FiO2 ratio increased significantly (from 201
± 103 to 283 ± 117 mm Hg, P = 0.009). Consequently,
the variation in PaO2/FiO2 ratio between T2 and T3
was significantly greater in the RM group than in the
control group (Figure 2a). As a whole, between T1 and
T3, the decrease in PaO2/FiO2 ratio was significantly
lower in the RM group than in the control group
(Figure 2b).
At the same time, the number of potential lung
donors with a PaO2/FiO2 ratio of greater than 300 mm
Hg decreased. In the whole population (n = 54) and
before the apnea test, the number of potential lung
donors (with a PaO2/FiO2 ratio of greater than 300 mm
Hg) was 21 (39%, 95% CI 26% to 53%): 12 in the control
group and 9 in the RM group. Two hours after the
apnea test, 7 of the 12 (58%, 95% CI 28% to 85%) poten-
tial donors did not meet the criteria any more in the
control group as compared with 0 of the 9 (0%, 95% CI
0% to 34%) in the RM group (P = 0.000) (Figure 3).
Complications of RM were studied in the 27 RM
potential donors. Hypotension occurred during the RM
in 15 cases (55%, 95% CI 37% to 72%), requiring infu-
sion of 500 mL of normal saline in 7 cases. In 5 patients
(19%, 95% CI 6% to 38%), this hypotension was resol-
ving after 15 minutes and, in only one patient (3%, 95%
CI 1% to 17%), was persistent after 30 minutes. One
case (3%, 95% CI 1% to 17%) of desaturation was
observed, and no case (0%, 95% CI 0% to 12%) of pneu-
mothorax or bradycardia was observed.
Discussion
Our study showed that the apnea test was associated
with a marked decrease in PaO2/FiO2 ratio, which could
be restored by an RM performed immediately after the
reconnection to the ventilator. Importantly, in relation
to arterial blood gas criteria for lung procurement elig-
ibility defined as a PaO2/FiO2 ratio of greater than 300
mm Hg, RM prevented the loss of potential lung
donors.
Around the world, there is a persistent and mounting
supply-demand discrepancy for lung transplants. Selec-
tion criteria were established almost 30 years ago and
continue to define the ‘standard’ lung donor to the pre-
sent day. The traditional features are age of 55 years or
less, clear chest radiography, PaO2/FiO2 ratio of 300
mm Hg or more, tobacco history of not more than 20






Age, years 51 ± 15 55 ± 15 0.35
Cause of brain death
Brain trauma 4 (15%) 8 (22%)
Stroke 18 (67%) 16 (59%) 0.38
Others 5 (19%) 3 (11%)
Sex
Male 19 (70%) 21 (78%) 0.76
Female 8 (30%) 6 (22%)
Weight, kg 76 ± 14 74 ± 13 0.54
Size, cm 173 ± 10 172 ± 9 0.89
Pulmonary disease history 1 (4%) 2 (7%) 1.00
History of smoking 8 (30%) 6 (22%) 0.75
Abnormal chest x-ray 4 (15%) 7 (26%) 0.50
Mean arterial blood pressure, mm Hg 87 ± 10 90 ± 20 0.63
Administration of catecholamine 23 (85%) 24 (89%) 1.00
Ventilatory settings
Tidal volume, mL 525 (500-550) 550 (500-600) 0.30
Respiratory frequency, per minute 12 (12-14) 12 (10-14) 0.16
Positive end-expiratory pressure, cm H2O 5 (5-5) 5 (5-5) 0.67
Duration of mechanical ventilation, hours 36 (22-48) 30 (23-48) 0.79
Duration of ventilation of more than 5 days 3 (11%) 4 (15%) 1.00
Data are expressed as mean ± standard deviation (SD), as median (25th to 75th interquartiles), or as number and percentage. RM, recruitment maneuver.
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packs per year, absence of chest trauma, no evidence of
aspiration/sepsis, absence of organisms detected by a
sputum Gram stain, absence of purulent secretions at
bronchoscopy, and a short period of mechanical ventila-
tion [3,12]. Historically, the vast majority of organ
donors have failed to meet these criteria, leading to lung
harvest rates of only 15% to 25%, the lowest rates of all
the major transplantable organs [13]. Among them,
PaO2/FiO2 ratio is a criterion variably reached in brain-
dead patients. In our study, on the basis of arterial
blood gas criteria, only 39% of patients were eligible for
lung procurement before the apnea test. In the series
reported by Mascia and colleagues [9], 54% of lung
donors in the control group met a PaO2/FiO2 ratio of
greater than 300 mm Hg and a peak airway pressure of
less than 30 cm H2O. This difference may be explained
because Mascia and colleagues excluded patients who
did not meet non-gasometric standard criteria for lung
procurement, which are obviously related to PaO2/FiO2
ratio. In our study, patients were older (mean of 53 ver-
sus 45 years), the duration of ventilation before the
apnea test was greater (mean of 51 versus 36 hours),
and the PaO2/FiO2 ratio before the apnea test was lower
(mean of 284 versus 396 mm Hg) in comparison with
the study by Mascia and colleagues. Moreover, the pro-
portion of patients who had a history of pulmonary dis-
ease or an abnormal chest x-ray was 24% in our study
whereas these patients were excluded in the study by
Mascia and colleagues.
During donor management and before the harvest,
many factors may impair the donor’s respiratory func-
tion: fluid overload, hemodynamic instability, endocrine
failure, nephrogenic diabetes insipidus, inflammatory
response, arrhythmias, hypothermia, coagulopathy, and
infection [14]. Other factors may be atelectasis due to
the use of a protective lung strategy and the apnea test,
used to assess the clinical diagnosis of brain death [15].
We confirmed the deleterious effect of the apnea test
on oxygenation. In our study, the apnea test was respon-
sible for the PaO2/FiO2 ratio decrease from 265 to 225
mm Hg. Because inadequate preoxygenation was found
to be associated with hypoxemia during the apnea test,
we took care to increase FiO2 to 1 for 15 minutes before
Figure 2 Variation of arterial oxygen tension/fractional inspired oxygen (PaO2/FiO2) ratio. (a) From the end of the apnea test before
reconnection (T2) to 2 hours after reconnection (T3). (b) From before the apnea test (T1) to 2 hours after reconnection (T3). Values are medians
with 25th and 75th percentiles (boxes) and 95th and 5th percentiles (whiskers). RM, recruitment maneuver.
Figure 3 Variation of percentage of potential lung donors
according to PaO2/FiO2 criterion (between T1 and T3 from
100% at T1. PaO2/FiO2, arterial oxygen tension/fractional inspired
oxygen. RM, recruitment maneuver.
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the apnea test [16]. Then, we showed that hypoxemia
may occur even after adequate preoxygenation. These
results are very close to those reported by Goudreau
and colleagues [16] during uncomplicated apnea tests,
in which the PaO2/FiO2 ratio fell from 248 to 206 mm
Hg.
Consequently, two options were available to increase
the supply of lungs available for transplantation: to
expand the eligibility criteria or to prevent hypoxemia.
Some teams have proposed decreasing the minimum
tolerated value of PaO2/FiO2 ratio to 225 mm Hg or
even removing this criterion in ‘marginal’ lungs being
considered, despite controversies about the conse-
quences [17]. Thabut and colleagues [2], reporting a ser-
ies of 785 lung donors, demonstrated a higher relative
risk of recipient death when donor PaO2/FiO2 ratio fell
to below 350 mm Hg. On the other hand, Luckraz and
colleagues [18] analyzed 362 lung transplants and found
a higher 30-day mortality but not a higher overall mor-
tality in the group of 52 donors with a PaO2/FiO2 ratio
of between 225 and 300 mm Hg. More recently, Reyes
and colleagues [19] found that 18% of the donors used
for transplantation did not meet ‘standard’ gasometric
criteria but that the post-transplant outcomes were simi-
lar to those of donors with a PaO2/FiO2 ratio of greater
than 300 mm Hg. Nevertheless, it should be a safer
strategy to improve the potential lung donors’ oxygena-
tion than to expand the criteria of eligibility for
procurement.
To improve oxygenation, Noiseux and colleagues [20]
proposed a lung recruitment protocol with intermittent
30-second periods of sustained inflation at 30 cm H2O.
They reported that, with this protocol, two thirds of the
lungs were suitable for transplantation after recruitment.
As they did not compare the data with those of donors
without a recruitment protocol, the exact benefit of the
protocol remains unknown. Recently, Mascia and collea-
gues [9] showed that a protective ventilatory manage-
ment of organ donors allowed the number of lung
transplantations to be increased. The authors tested a
global strategy of optimizing lung function to success-
fully harvest twice as many lungs according to standard
eligibility criteria (including a PaO2/FiO2 ratio of greater
than 300 mm Hg). The global strategy included protec-
tive ventilation (with tidal volumes of 6 to 8 mL/kg of
predicted body weight), PEEP of 8 to 10 cm H2O, an
RM performed after any disconnection from the ventila-
tor, an apnea test performed by using continuous posi-
tive airway pressure, and a closed circuit for airway
suction. Because of global protective respiratory man-
agement, it was not possible to ascribe the improvement
in respiratory function to a specific modification, espe-
cially to RM. Our study was therefore designed to
answer this question.
After apnea induced by general anesthesia and paraly-
sis, RMs are effective to re-expand atelectasis and
improve oxygenation in healthy subjects [7]. In morbidly
obese patients, Reinius and colleagues [21] showed that a
single RM followed by PEEP was efficient to reduce the
amount of atelectasis and to correct the impairment of
oxygenation induced by anesthesia. In brain-dead
patients, we have shown that a single RM followed by
PEEP might restore oxygenation impaired by an apnea
test. Moreover, this strategy may improve the rate of
lung procurement. Indeed, in our control group, 58% of
the potential lung donors before the apnea test were lost
after the apnea test. Conversely, no potential lung donor
was lost in the RM group. This result is important since
only 39% of our potential donors met the criteria for
lung procurement, compared with 95% in the treated
group of Mascia and colleagues [9], because of a different
selection of potential lung donors (as detailed above).
RMs may have some potential adverse effects. In parti-
cular, excessive pressure may cause transient hemody-
namic instability, especially in hypovolemic patients
[22]. It is known that 80% of brain-dead patients have
hemodynamic instability and that many factors may
induce real or relative hypovolemia, such as diabetes
insipidus, adrenal insufficiency, and sepsis [23]. Despite
taking care to correct hypovolemia before an apnea test,
we could not prevent all hypotensive episodes. However,
these episodes were quickly resolved, either sponta-
neously or after fluid administration, and no serious
complication such as pneumothorax, extreme bradycar-
dia, or cardiac arrest was observed.
Our study had certain limitations that should be
noted. The control group was historic. However, rando-
mization was impossible because French law requires
informed consent, which is impossible to obtain from
brain-dead patients. However, the matching of patients
allowed us to have comparable groups, especially under
initial pulmonary conditions. In addition, our study
included a relatively small number of patients, but the
effect of RM, both expected and demonstrated, was so
important that the power of the study remained good.
Unlike investigators in a study of patients with acute
lung injury [24], we did not try to detect atelectasis and
effect of RM through computed tomography scans.
However, 55% of our patients were hemodynamically
unstable, making any move to the radiology unit poten-
tially deleterious. Lastly, the choice of RM technique
requires discussion [25,26]. We chose a sustained high-
pressure inflation using a PEEP of 35 cm H2O for a
duration of 40 seconds for the sake of simplicity. The
PEEP of 35 cm H2O was limited by the settings possible
on our ventilator. The choice of this procedure seemed
to be the easiest implementation and the most reprodu-
cible by all physicians.
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Conclusions
Our study showed that the apnea test was associated
with impairment in respiratory function in potential
organ donors, and this may limit the eligibility for
donor lung harvest. A single RM applied just after
reconnection to the ventilator prevented the decrease of
PaO2/FiO2 ratio and may prevent the loss of potential
lung donors. Our study suggests that an RM should be
routinely applied after the apnea test in potential lung
donors.
Key messages
• The apnea test, used to assess the clinical diagnosis
of brain death, may be associated with impairment
in oxygenation in potential organ donors and may
limit the eligibility for donor lung harvest.
• A single recruitment maneuver applied just after
reconnection to the ventilator prevents the decrease
of PaO2/FiO2 ratio and may prevent the loss of
potential lung donors.
Abbreviations
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